Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $11.36 Analyst target: $19.27 Upside: 69.63%
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.